![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » EISAI SUBSIDIARY LAUNCHES RESEARCH OPERATIONS IN KOBE
EISAI SUBSIDIARY LAUNCHES RESEARCH OPERATIONS IN KOBE
October 5, 2006
KAN Research Institute, Eisai's research subsidiary, has begun research operations in its new facilities in the Kobe Medical Industry Development Project site. KAN aims to discover innovative ideas and technology that lead to new pharmaceutical development, focusing on cellomics in order to explore how cells interact with each other and orchestrate to shape vital activities of a human body. JCN Network (http://www.japancorp.net/Article.Asp?Art_ID=13501)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct